Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy
Jing Zhou(Sichuan Agricultural University), Guo‐Dong Lu(Guangxi University)
Cited by 35
Related Papers
Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion
|Cell Research|2013|395
Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma
|Acta Pharmacologica Sinica|2020|300
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma
|Acta Pharmacologica Sinica|2020|161